division-head
Novartis executive exodus complicates drugmaker’s rebuilding job
May 23, 2016 by creative · Leave a Comment
By John Miller ZURICH (Reuters) – With seven departures in the space of five months, Novartis's top management is in upheaval just as CEO Joe Jimenez tries to tackle a list of challenges that have seen the drug firm's share price fall 25 percent since July. The most dramatic exit came last week, when head of pharmaceuticals David Epstein quit as his division was broken in two. By splitting oncology into a department of its own, Novartis aims to make the most of…
Read the rest here:
Novartis executive exodus complicates drugmaker’s rebuilding job